During a period of 10 months, inter and intraindividual variations in plasma cholinesterase (ChE) activity were studied in 331 employees of an organophosphorus insecticide factory, and in 193 healthy volunteers without occupational exposure to known ChE inhibitors. Repeated (n = 6) measurements of ChE activity and ChE substance concentration were performed in 410 subjects. The study showed substantial intraindividual variations of ChE activity and ChE substance concentration (up to 40%) in the employees and in the reference group. When effects due to sex, ChE-1 phenotype, body weight, and height were considered, one subgroup of employees of the organophosphorus insecticide factory showed a significantly lower average ChE activity than other subgroups; as ChE substance concentrations were found to be proportionally decreased, it was concluded that the low ChE activity was unrelated to occupational exposure. A combined determination of ChE activity and ChE substance concentration is recommended as a rational diagnostic tool when an unexpected decrease of plasma ChE activity is registered in people joining organophosphorus insecticide health surveillance programmes.
Inter and intraindividual variations in plasma cholinesterase activity and substance concentration in employees of an organophosphorus insecticide factory A Brock Abstract During a period of 10 months, inter and intraindividual variations in plasma cholinesterase (ChE) activity were studied in 331 employees of an organophosphorus insecticide factory, and in 193 healthy volunteers without occupational exposure to known ChE inhibitors. Repeated (n = 6) measurements of ChE activity and ChE substance concentration were performed in 410 subjects. The study showed substantial intraindividual variations of ChE activity and ChE substance concentration (up to 40%) in the employees and in the reference group. When effects due to sex, ChE-1 phenotype, body weight, and height were considered, one subgroup of employees of the organophosphorus insecticide factory showed a significantly lower average ChE activity than other subgroups; as ChE substance concentrations were found to be proportionally decreased, it was concluded that the low ChE activity was unrelated to occupational exposure. A combined determination of ChE activity and ChE substance concentration is recommended as a rational diagnostic tool when an unexpected decrease of plasma ChE activity is registered in people joining organophosphorus insecticide health surveillance programmes.
Organophosphorus insecticides are highly toxic substances to man as well as to pests. Persons with risk for substantial occupational exposure to such substances are employees of organophosphorus insecticide factories and pesticide operators within gardening and agriculture. Because even a few mg may possess appreciable toxic effects in man, and as absorbed organophosphorus insecticides are excreted as non-specific metabolites (for example, pnitrophenol from parathion and methyl-parathion), most programmes for health surveillance are based on measurements of plasma cholinesterase activity (ChE, pseudocholinesterase, butyrylcholinesterase, acylcholine acylhydrolase, EC 3.1.1.8), which is strongly inhibited by all organophosphorus insecticides.' In such health surveillance programmes (as in other areas of clinical medicine) decisions should be made from rational interpretations of observed variations based on knowledge of spontaneous inter and intraindividual variations in the population.2
Biosynthesis of the 574 amino acid ChE subunit3 is controlled by the ChE-1 locus on chromosome No 3, where a number of alleles (ChEu, ChEa, ChEf, ChEs, ChE), ChEk) define the actual genotype4; the genotype ChEUChEu (u = usual) is found in about 95% of Caucasian populations. About 4% should be expected to be ChEUChES (a = atypical); the atypical ChE has recently been shown to be an Asp-70 -> Gly mutation owing to a change of the actual ChEa codon from GAT to GGT.5 Within a Caucasian population one person in 100 000 will be expected to be of ChE-1 genotype ChESChES (s = silent) without detectable ChE catalytic activity in plasma. Such people, who are found much more frequently among the Inuits of the north-western parts of Canada than among a general population (Dr Alison Dinwoodie, University of Alberta, Canada, personal communication), are healthy and without any increased risk of death unless exposed to suxamethonium to which they are extremely sensitive.4
Previous studies"'0 have analysed the well known, wide interindividual variation in plasma ChE activity in healthy subjects. Such Table 2 shows the total ChE activity in six plasma samples (ChE-1-ChE-6) from the 449 subjects (employees 318; reference group 131) who completed the full programme. It shows the well known wide interindividual variation that may conceal a treatment effect when comparing unmatched groups and subgroups. As described earlier,'0 this problem is partly overcome by comparing "standardised" ChE activities (from which the effect of varying body weight, height, sex, and ChE-1 phenotype is eliminated) instead of "raw" ChE activities. The right column of the Table 5 shows the maximum intraindividual variations and intraindividual variations expressed as individual SD (n = 6). As in the reference group,'3 the distribution of intraindividual variations of the employees of the organophosphorus insecticide factory was skewed to the right. Average maximum variation was 18 7% (range: 3-43%), independent of actual risk group, and similar to that of the reference group (mean: 20%, range: 6-43%). Within the 316 employees, a repeated measures analysis of variance showed an average SDi.,. of 0 41 mg/l (reference group: SDi.,r. = 044 mg/l).
Discussion
The use of plasma ChE activity measurements for biological monitoring should not be confused with relating the enzymatic activity to clinical or toxicological effects. Earlier systematic studies of ChE after exposure to the toxic organophosphorus compound DFP (diisopropylfluorophosphate) showed up to 95% reduction of plasma ChE activity after parenteral administration of0 5-3-0 mg."'8No close relation between toxic symptoms and changes in plasma ChE activities were seen. Although distinct organophosphorus insecticides inhibit plasma ChE to a varying extent,' and although plasma ChE differs in amino acid sequence from the target enzyme for organophosphorus insecticides (acetylcholinesterase EC 3.1.1.7), the use of plasma ChE activity for monitoring exposure to organophosphorus insecticides offers great advantages compared with erythrocyte acetylcholinesterase, which (contrary to plasma ChE) appears quite instable, even when stored at -20'C (A Brock, unpublished observations).
When comparing plasma ChE activity in unmatched groups or subgroups, influence by factors other than organophosphorus inhibitors has to be considered. The effects by ChE-1 phenotype and sex are well known,47 '4 but also (as in other liver synthesised plasma enzymes'9) varying body weight and height has appeared to affect the interindividual variation of plasma ChE activity'0 as well as plasma ChE substance concentration. ' Even when considering all Table 6 shows ChE specific catalytic activities by ChE-1 phenotype, which is the only physiological factor known to influence this quantity.'3 The specific catalytic activity of subjects in risk group 3 equals those of the other groups and subgroups. As inhibition of ChE activity by organophosphorus insecticides (phosphorylation of the catalytic active site') does not influence the plasma turnover rate,4 it was concluded that risk group 3 was not subjected to disproportionate exposure. In health surveillance programmes, changes in plasma ChE activity are used to indicate occupational exposure of the person to organophosphorus insecticides. In accordance with earlier studies689 (each based on 22-24 subjects) the present study, including Table 7 Intraindividual variation of ChE specific activity (n = 6) in employees of an organophosphorus insecticide factory and in healthy subjects without occupational exposure to known ChE inhibitors (referenced group) shown to have fallen by more than 30% of preexposure levels." This strategy, which corresponds with the intraindividual variation of ChE activity found in the present study (only four of the 318 employees showed intraindividual variations higher than 30%), might be replaced by a strategy based on variations of ChE specific activity that within healthy persons exhibit insignificant biological intraindividual variations.'3 Unfortunately, the actual analytical imprecision of the ELISA assay for ChE substance concentrations (CV = 5-5 5%) so far eliminates most of the theoretical advantages of a strategy based on this quantity (table 7) .
Until a real improvement in analytical precision of the ChE substance assay is achieved, ChE specific catalytic activity will be oflimited value when dealing with minor intraindividual changes of ChE activity. When comparing groups and subgroups within a health surveillance programme and when unexpected large intraindividual variations in plasma ChE activity are to be interpreted, measurement of plasma ChE specific activity must be considered as a rational diagnostic tool. 
